Sun.Sep 15, 2024

article thumbnail

Unlocking the Power of Stem Cells in Skincare: A Comprehensive Guide

Kim Gallo Esthetics

We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission In the ever-evolving world of skincare, stem cells have emerged as one of the most promising ingredients, sparking interest and curiosity among beauty enthusiasts and professionals alike. This guide aims to demystify the role of stem cells in skincare, explaining their benefits, how they work, and how to integrate them into your beauty routine for optimal results.

Skincare 197
article thumbnail

Meet the 2025 National Psoriasis Foundation Commit to Cure Gala Honorees

The Dermatology Digest

Joel M. Gelfand, MD, Carol Ostrow, and Jose U. Scher, MD, will be honored at The National Psoriasis Foundation (NPF) 2025 Commit to Cure Gala in New York City. The Gala, NPF’s annual flagship fundraising event, is slated to be held on Wednesday, June 18, 2025. “We are thrilled to honor Carol, Joel, and Jose in New York this June. Joel and Jose have been instrumental in shaping the landscape of psoriatic disease research, while Carol is our current Chair of the Board of Directors and has been a

Clinic 73
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Previewing Maui Derm NP+PA Fall 2024: Will You Be There?

Dermatology Times

The conference aimed at providing dermatology NPs and PAs clinicians with the latest updates in the specialty begins today in Nashville, Tennessee.

article thumbnail

Study Examines Sex-specific Trends in Melanoma

The Dermatology Digest

Melanoma rates differ consistently between men and women in terms of the age of onset and the locations on the body where the cancers occur, new research confirms. The study is published in the Journal of Investigative Dermatology. The research team analyzed more than 40 years of melanoma data from Queensland, Australia, the USA, and Scotland. These three populations were chosen because historically they have had high (Queensland), moderate (USA), and low (Scotland) rates of melanoma.